In this article, we will take a detailed look at 10 stocks with at least $30 million in insider sales recently. We previously covered 10 stocks with at least $20 million in insider sales recently.
Last week, stocks declined in part due to President Donald Trump’s statements on tariffs. This week, the turbulent ride on the stock market continues as stocks react to the President’s comments on a potential recession.
In an interview on Fox News’ “Sunday Morning Futures with Maria Bartiromo” that aired Sunday, Trump discussed the U.S. economy, stating it is “a period of transition,” and did not rule out a possible recession, according to CNN Business. When directly asked if he was expecting one, the President responded, “I hate to predict things like that. There is a period of transition because what we’re doing is very big.”
The very big U.S. indexes reacted to the news, with blue-chip companies dropping by 1%, and the broader market index losing 2%. The NASDAQ, which already entered correction last week, fell another 3% today. Tech stocks were leading the sell-off.
As the market adapts to new political and economic developments, some analysts remain optimistic, with faith in the future adoption of AI technology. During these market fluctuations, insider trading often attracts attention, as executives have valuable insights into their company’s future. For instance, when a CEO or CFO buys company stock, it can signal confidence in the company’s prospects.
On the other hand, selling shares may indicate a lack of confidence, though it’s not always the case. Insiders may sell for reasons like portfolio rebalancing or personal financial needs, and many follow pre-arranged trading plans (10b5-1 plans).
While insider buying or selling can offer useful clues, it should be considered alongside a company’s financial health, industry trends, and market conditions. Research is key to making informed investment decisions.
A trader on the floor of a stock exchange, his face illuminated by the financial tickers.
Today, we’re focusing on stocks that have seen insider sales of at least $30 million since the start of the year. Using Insider Monkey’s insider trading screener, we identified stocks where at least one insider sale reached $30 million or more. While the total value of insider sales for these stocks could be higher, we specifically selected the stocks with the single largest insider sale above $30 million. From this group, we highlighted the 10 stocks with the highest individual insider sales.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
For each stock, we provide details on the highest individual sale, the number of insider sales exceeding $30 million year-to-date, and the company’s current market capitalization. Let’s take a look at 10 stocks with at least $30 million in insider sales since the beginning of the year.
10. Smithfield Foods, Inc. Common Stock (NASDAQ:SFD)
Highest Individual Sale: $260,869,580.00
Number of Sales Above $30 million: 2
Market Capitalization: $7.59 billion
We begin this list with a global food company and one of the largest pork processors and hog producers in the world, Smithfield Foods. The company went public in January. Smithfield’s diverse portfolio includes popular brands such as Smithfield, Eckrich, Nathan’s Famous, Farmland, Farmer John, and Armour. Founded in 1936 as Smithfield Packing Company, it is now ranked among the 15 biggest agriculture stocks in 2025.
On February 29, one insider sold $260.87 million worth of Smithfield shares at a price of $20 per share. The stock is now trading at $18.91, having declined 4.25% since its IPO in January.
Seven analysts have given a “Moderate Buy” rating to Smithfield stock with a price target of $27.67, according to MarketBeat. The average price target is $32, representing a 46.54% upside.
9. Cencora, Inc. (NYSE:COR)
Highest Individual Sale: $264,531,701.35
Number of Sales Above $30 million: 2
Market Capitalization: $49.32 billion
Cencora, previously known as AmerisourceBergen Corporation sources and distributes pharmaceutical products both in the U.S. and internationally. The Conshohocken, Pennsylvania-headquartered company operates in two segments – U.S. Healthcare Solutions and The International Health Solutions. Across the U.S. Cencora provides pharmaceuticals, over-the-counter products, home healthcare supplies, and related services to hospitals, pharmacies, clinics, and long-term care providers. It also offers pharmacy management, staffing, packaging, clinical trial support, and data analytics services. Additionally, it distributes animal health products, blood products, vaccines, and specialty drugs to various healthcare providers.
On February 2, one insider sold $264.53 million worth of Cencora shares for $244.51 per share. Year-to-date, the stock is up 16.03%, trading at $260.69 per share. Over the past 12 months, Cencora brought back 9.68% to its investors.
On February 6, the company confirmed it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares.
Cencora also recently reported that in its fiscal year 2025 first quarter revenue increased 12.8% year-over-year to $81.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.50 for the first quarter of fiscal 2025 compared to $2.98 in the prior year first quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, increased 13.7% to $3.73 in the fiscal first quarter from $3.28 in the prior year first quarter.
According to 10 analysts, Cencora stock is a “Buy” with a price target of $274.8, writes StockAnalysis. The average price target presents a 5.25% upside from the previous price.
Cencora is one of the top 10 stocks analysts are watching as AI selloff deepens.
8. Life Time Group Holdings, Inc. (NYSE:LTH)
Highest Individual Sale: $297,433,929.31
Number of Sales Above $30 million: 6
Market Capitalization: $6.10 billion
Life Time Group offers a wide range of health, fitness, and wellness experiences to members across the U.S. and Canada. The Chanhassen, Minnesota-headquartered company specializes in designing, building, and operating sports, fitness, family recreation, and spa centers in resort-style environments in both suburban and urban locations. Its facilities feature fitness floors with equipment, locker rooms, group fitness studios, indoor and outdoor pools, tennis and pickleball courts, basketball courts, LifeSpa, LifeCafe, and childcare spaces like Kids Academy.
In addition, Life Time Digital offers live-streamed fitness classes, remote personal training, nutrition and weight loss support, and curated health and wellness content. The company also provides media, athletic events, and related services.
Recently, the company announced the opening of Life Time Evanston, the 14th Life Time in Illinois, and the company’s second athletic country club in the country to feature its exclusive MIORA Performance and Longevity Clinic. Located near the scenic shores of Lake Michigan, the 60,000 square-foot destination extends Life Time’s signature healthy way of life programs and services to the downtown Evanston area with an unparalleled health and wellness experience for those 90 days old to 90 years old.
Since the beginning of the year, Life Time shares gained 27.40%, now trading at $28.18 per share. Additionally, the stock returned 91.05% to its investors over the past 12 months.
In 2024 Life Time had revenue of $2.62 billion, compared to $2.22 billion in 2023. Net income amounted to $156.2 million, up by 105% from $76.1 million in 2023. Adjusted EBITDA was a gain of $676.8 million, compared to $536.8 million in the prior year.
According to data from Tip Ranks, 11 Wall Street analysts have given a “Moderate Buy” rating to Life Time stock. The average price target of $36.50 represents an increase of 29.43%. More specifically, analyst John Baumgartner from Mizuho Securities maintained a “Buy” rating on the company’s stock and has a $38.00 price target. The rating was backed by factors highlighting the company’s strong performance and growth potential.
Life Time is among stocks on the rise: 10 best stocks to buy right now.
7. Zurn Elkay Water Solutions Corp (NYSE:ZWS)
Highest Individual Sale: $299,460,000.00
Number of Sales Above $30 million: 3
Market Capitalization: $5.96 billion
Seventh among the 10 stocks with at least $30 million in insider sales since the beginning of the year is a leader in sustainable water solutions, Zurn Elkay Water Solutions Corporation. The Milwaukee, Wisconsin-headquartered company designs, manufactures, and markets water management solutions across the U.S., Canada, and internationally. It offers a wide range of products, including water dispensers, filtration systems, faucets, backflow preventers, and valves under the Elkay, Halsey Taylor, Zurn, and Wilkins brands. It also provides flow systems, oil and grease interceptors, sensor-operated flush valves, heavy-duty commercial faucets, water-conserving fixtures, sinks, and restroom products.
For the full year of 2025, Zurn Elkay reported net sales of $1.57 billion, up by 2% from $1.53 billion in 2023. Net income from continuing operations was $159 million or $0.91 per diluted share, which compares with $104 million or $0.59 per diluted share in the prior year. Adjusted EBITDA amounted to $390 million, compared to adjusted EBITDA of $340 million in 2023. In 2024, the company completed $150 million of common stock repurchases and paid $57 million in common stock dividends.
On February 13, two insiders sold $299.46 million of Zurn Elkay shares each, at a price of $33.60 per share. Currently, the stock is trading at $35.04 per share, having declined 6.06% since the beginning of the year. Over the past 12 months, Zurn Elkay returned 11.13% to its investors.
Six analysts have given a “Moderate Buy” rating to Zurn Elkay stock with an average price target of $38.67, according to MarketBeat. The average price target suggests an upside of 10.53%.
6. CCC Intelligent Solutions Holdings Inc (NASDAQ:CCCS)
Highest Individual Sale: $318,096,399.60
Number of Sales Above $30 million: 8
Market Capitalization: $2.22 billion
CCC Intelligent Solutions is a provider of cloud, mobile, AI, telematics, and hyperscale technologies and applications tailored for the property and casualty insurance industry. Its SaaS platform connects trading partners, streamlines commerce, and supports essential AI-driven digital workflows.
In 2024, the company had revenue of $944.8 million, representing an increase of 9% from 2023. GAAP gross profit was $713.8 million and GAAP net income amounted to $31.2 million, which compares to GAAP gross profit of $636.2 million and GAAP net loss of $90.1 million in 2023. Adjusted EBITDA was $397.4 million for the full year of 2024, compared with adjusted EBITDA of $353.4 million for the full year of 2023.
At the end of the reporting period, the company had $399 million in cash and cash equivalents and $776 million of total debt.
On March 3, four investors sold $318.1 million worth of shares each at a price of $10.33 per share. Year-to-date, CCC Intelligent Solutions shares declined 22.38% and are now trading at $9.11 per share. Over the past 12 months, the stock dropped 26.61%.
Four Wall Street analysts have an average “Moderate Buy” rating on CCC Intelligent Solutions stock, according to Tip Ranks. The average price target is $13.33, suggesting an increase of 46.16% from the last price of $9.12.
5. Oracle Corporation (NYSE:ORCL)
Highest Individual Sale: $376,772,482.94
Number of Sales Above $30 million: 4
Market Capitalization: $433.98 billion
In the middle of this list of 10 stocks with at least $30 million in insider sales recently is a leading multinational technology company, Oracle. The Austin, Texas-headquartered company was the third-largest software company globally by revenue and market capitalization in 2020. In 2023, it ranked 80th on the Forbes Global 2000 list.
Oracle’s specialty is database software, particularly Oracle Database, and cloud computing services. Oracle’s core offerings include a range of enterprise software products such as enterprise resource planning (ERP), human capital management (HCM), customer relationship management (CRM), enterprise performance management (EPM), Customer Experience Commerce (CX Commerce), and supply chain management (SCM) software.
On January 22, Oracle’s CEO, Safra Catz, sold $376.77 million worth of the company’s shares at a price of $185.29 per share. Since the beginning of the year, the stock declined 10.10% and is now trading at $149.81. However, over the past 12 months, Oracle returned 31.09% to its investors.
Mad Money host, Jim Cramer, recently talked about Oracle, and said “Now Oracle, a very good software company’s become a great data center company, which was terrific until we learned that some Chinese outfit could create high-quality AI models using … much less hardware.“ Cramer added that he expects Oracle to report solid earnings for the third quarter of fiscal 2025.
Twenty-eight analysts have given Oracle a “Buy” rating forecasting a price of $186.24, according to Stock Analysis. The average price target represents an upside of 25.11% from the latest price.
Oracle is also one of the top 10 stocks everyone is talking about these days.
4. Waystar Holding Corp. (NASDAQ:WAY)
Highest Individual Sale: $393,205,720.00
Number of Sales Above $30 million: 4
Market Capitalization: $6.44 billion
Waystar Holding develops cloud-based software solutions for healthcare payment processing. Its platform offers a range of services, including revenue capture, patient financial care, denial prevention and recovery, reporting and analytics, financial clearance, and claim and payment management. The Lahi, Utah-based company services around 30,000 clients, representing more than 1 million distinct providers and 16 of 20 institutions on the News Best Hospitals Honor Roll. Waystar’s enterprise-grade platform annually processes over 6 billion healthcare payment transactions, including over $1.8 trillion in annual gross claims and spanning approximately 50% of patients.
Waystar’s recent market survey of 600 healthcare leaders highlights the top revenue cycle management (RCM) trends for 2025. The study shows that AI and advanced automation are key priorities, particularly for patient access and claim management.
For the fourth quarter of 2024, Waystar reported revenue of $244.1 million, up 18% year-over-year. Net income amounted to $19.1 million, compared to a net loss of $14.42 million in the same quarter of 2024. Adjusted EBITDA was $100.2 million, which compared to adjusted EBITDA of $86.2 million in the corresponding period of the prior year.
In 2025 the company expects total revenue between $1.0 billion and $1.016 billion and adjusted EBITDA between $399 and $407 million.
On February 24, one insider sold $393.21 million worth of Waystar shares at a price of $40 per share. Year-to-date, the stock grew 0.68%, currently trading at $36.95 per share. Since the company’s IPO in June last year, Waystar returned 76.59% to its investors.
As per 11 market analysts, Waystar is a “Strong Buy” and its 12-month stock price target is at $41.14, writes Stock Analysis.
Waystar is also among the top 10 health information services stocks outpacing the market in 2025.
3. Nutanix, Inc. (NASDAQ:NTNX)
Highest Individual Sale: $409,805,000.00
Number of Sales Above $30 million: 2
Market Capitalization: $18.78 billion
The third stock among 10 with a minimum of $30 million in recent insider sales is a cloud computing company, Nutanix. The San Jose, California-headquartered firm provides software solutions for data centers and hybrid multi-cloud environments. Its offerings include software for virtualization, Kubernetes, database-as-a-service, software-defined networking, security, and software-defined storage for file, object, and block storage.
Nutanix has evolved from its initial hyper-converged infrastructure (HCI) offering into a comprehensive hybrid multi-cloud platform that empowers businesses to run applications both on-premises and across public clouds such as AWS and Azure. The company has expanded its capabilities to include a fully integrated cloud-native platform for Kubernetes applications and enterprise AI solutions, positioning itself as a versatile platform for both current and future computing needs. It has also strengthened its strategic alliances, particularly with Cisco and Dell, while establishing key relationships with major cloud providers like AWS to support seamless workload migration.
On March 3, two insiders sold $409.81 million worth of Nutanix shares each. The insiders sold 5.5 million shares each, at a price of $74.51 per share. Since the beginning of the year, Nutanix stock grew 15.09%, and its shares are now trading at $70.41 per share. Investors who invested in Nutanix, have seen an 11.13% return on their investment.
For the second quarter of fiscal 2025, the company disclosed revenue of $654.7 million, an increase of 15% year-over-year from $565.2 million. Free cash flow during the quarter was $187.1 million, compared to free cash flow of $162.6 million in the second quarter of fiscal 2024.
For the third quarter of fiscal 2025, the company projects revenue in the range of $620 million to $630 million, and a non-GAAP operating margin of 17% to 18%. The outlook for the full fiscal 2025 suggests revenue between $2.495 billion to $2.515 billion.
Nutanix’s seventh annual Enterprise Cloud Index (ECI) survey reveals that Generative Artificial Intelligence (GenAI) adoption is rapidly accelerating, with over 80% of organizations already implementing a GenAI strategy. While GenAI promises productivity, automation, and innovation, companies face challenges in scaling workloads, data security, privacy, and modernizing IT infrastructure. Many organizations expect rising IT costs due to GenAI, but 70% anticipate a return on investment within the next 2-3 years.
As per MarketBeat, fifteen analysts believe Nutanix is a “Buy”, forecasting a price of $87.79.
The stock is also considered one of the 10 best growth stocks under $100 to buy now.
2. Hess Midstream LP (NYSE:HESM)
Highest Individual Sale: $430,210,000.00
Number of Sales Above $30 million: 2
Market Capitalization: $9.2 billion
Hess Midstream LP is an owner, developer, operator, and acquirer of midstream assets, offering fee-based services to both Hess and third-party customers across the United States. The Houston, Texas-based company operates through three primary segments: Gathering, Processing and Storage, and Terminaling and Export.
The Gathering segment is responsible for natural gas gathering and compression systems, crude oil gathering systems, and produced water gathering and disposal facilities. Its gathering network spans approximately 1,410 miles of high- and low-pressure natural gas and natural gas liquids gathering pipelines.
The Processing and Storage segment includes a natural gas processing and fractionation plant in Tioga, North Dakota, along with a 50% ownership stake in the Little Missouri 4 gas processing plant south of the Missouri River in McKenzie County, North Dakota. It also encompasses the Mentor Storage Terminal in Mentor, Minnesota, which features a propane storage cavern and rail and truck loading and unloading facilities.
The Terminaling and Export segment owns several key assets, including the Ramberg terminal facility, the Tioga rail terminal, crude oil rail cars, and various connections to the Dakota Access Pipeline. Additionally, it operates the Johnson’s Corner Header System, a crude oil pipeline header system.
The company recently reported earnings for 2024, revealing a net income of $659.0 million, compared to a net income of $607.7 million in 2023. Revenue was $1.5 billion, which compares to a revenue of $1.4 billion in the prior year. Adjusted EBITDA amounted to a gain of $1.14 billion, compared to adjusted EBITDA of $1.02 billion in 2023.
Hess Midstream noted that in 2024 its throughput volumes increased 14% for gas processing, 7% for terminaling and 32% for water gathering compared with 2023, primarily due to increased Hess drilling activity and higher gas capture. The company also finalized the repurchase of a total of 8.36 million Class B Units of the Partnership from the Sponsors for around $300 million.
The company has been growing its dividends for the past six years and it currently pays a quarterly dividend of $0.6175 per share. The stock’s dividend yield on January 19 came in at 7.63%. It is among the dividend challengers list ranked by yield: top 10.
On December 2, one insider sold $430.21 million worth of Hess Midstream shares for $39.11 per share. Year-to-date, the stock went up 8.91% and is now trading at $40.33 per share. Over the past 12 months, Hess Midstream shares returned 13.61% to its investors.
According to three Wall Street analysts, Hess Midstream stock deserves a “Moderate Buy” rating, and the price target is $44.67, data from TipRanks shows. The average price target represents 10.76% from the previous price.
1. Keurig Dr Pepper Inc. (NASDAQ:KDP)
Highest Individual Sale: $2,740,967,500.00
Number of Sales Above $30 million: 1
Market Capitalization: $45.23 billion
First among the 10 stocks with at least $30 million in insider sales since the beginning of the year is a leading beverage and coffeemaker, Keurig Dr Pepper. The company was formerly known as Green Mountain Coffee Roasters and Keurig Green Mountain. Established in 2018 through the merger of Keurig Green Mountain and Dr. Pepper Snapple Group, the company offers over 125 hot and cold beverages. It is home to the #1 single-serve coffee system in the U.S. (Keurig) and has propelled Dr. Pepper to become the second-largest soft drink brand in the country, surpassing Pepsi by the end of 2023. Keurig Dr Pepper is also one of the 10 stocks insiders spent the most money on recently and one of the 7 best sugar stocks to buy according to analysts.
Recently, Keurig Dr Pepper unveiled its new 2025 flavor lineup in the U.S., featuring well-known brands such as Dr. Pepper, 7UP, A&W, and Snapple. This release follows the success of Dr. Pepper Creamy Coconut, the company’s most popular limited-time-offering carbonated soft drink (CSD) to date, as well as the introduction of Canada Dry Fruit Splash Cherry, which topped the charts as the most successful new CSD flavor innovation of 2024.
On February 26, one insider sold $2.74 billion worth of shares at a price of $32.65 per share. Currently, the stock is trading at $33.34 per share, having gained 3.80% since the beginning of the year. Over the last 12 months, the stock returned 13.79% to its investors.
In 2024, Keurig Dr Pepper had net sales of $15.35 billion, compared to $14.81 billion in 2023. Gross profit amounted to $8.53 billion, which compares to a gross profit of $8.08 billion in the prior year. Net income was $1.44 billion or $1.06 per share, compared to a net income of $2.18 billion or $1.56 per share.
“We strengthened our free cash flow generation, which funded dynamic capital allocation activities,” said the company’s CEO, Tim Cofer, during the company’s earnings call. “These included $1.1 billion of share buybacks, our fourth consecutive annual dividend increase, and over $1 billion of strategic investments that will enhance our ability to deliver consistent, profitable growth in the future. Our strategy and the five pillars underpinning it represent our North Star. In 2025, we will set a high bar for operational excellence, while further advancing each of these pillars as we become an ever stronger and more advantaged beverage company. To summarize our full-year 2024 financial performance, we delivered results consistent with our long-term algorithm, with constant currency net sales growing approximately 4% and EPS growing 8%.”
Thirteen analysts have an average “Buy” rating on Keurig Dr Pepper stock with a 12-month stock price target of $38.23 per share. The average price target suggests a 14.67% upside from the latest price.
Overall, KDP ranks first among the 10 stocks with at least $30 million in insider sales recently. While we acknowledge the potential of KDP, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than KDP but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
